NEW YORK (
) -- Stocks finished Monday mixed as
Dow Jones Industrial Average
dropped 11.28 points, or 0.09%, to close at 12,709.20 Monday. The
rose 0.6 points to settle at 1316 and the
fell 2.53 points to 2,784.17.
Breadth within the Dow was positive with 17 of the index's 30 components posting gains;
The biggest percentage decliners among the blue chips were
Procter & Gamble
Travelers' shares fell 2.1% to $60.28.
gives Travelers a
with a buy rating and price target of $69.65.
The financial services and insurance giant is slated to report its fiscal fourth-quarter results before Tuesday's opening bell, and Wall Street is expecting a profit of $1.53 a share on revenue of $$5.47 billion in the December-ended period.
Procter & Gamble fell 1.8% to $65.03. The stock was downgraded to hold from buy at Stifel Nicolaus.
gives Procter & Gamble an
with a buy rating and a price target of $76.32.
Verizon shares fell 1.4% to $38.43. The communications giant is also due to report its fiscal fourth-quarter results on Tuesday. The average estimate of analysts polled by
is for earnings of 53 cents a share in the quarter on revenue of $28.39 billion.
Verizon receives an
with a buy rating and a price target of $46.64.
On the positive side,
Bank of America
each rose more than 1%.
Besides Verizon and Travelers,
Johnson and Johnson
all the other Dow components due to report their quarterly results on Tuesday.
Shares of McDonald's fell 79 cents to $100.95 on Monday. The average estimate of analysts polled by
is for earnings of $1.30 a share for the December-ended quarter from Mickey D's on revenue of $6.81 billion.
gives McDonald's an
with a buy rating and price target of $121.65.
DuPont shares ticked down 7 cents to $49.35. Wall Street is expecting a profit of 33 cents a share in the December quarter on revenue of $8.53 billion from the chemicals giant.
gives DuPont a
with a buy rating and a price target of $57.06.
Shares of Johnson & Johnson fell 27 cents to $65. The consensus view for a profit of $1.09 a share from New Brunswick, N.J>-based J&J on revenue of $16.27 billion in its fiscal fourth quarter.
Johnson & Johnson receives an
with a buy rating and a price target of $75.29.
Written by Alexandra Zendrian in New York.
>To contact the writer of this article, click here:
>To submit a news tip, send an email to:
>To follow the writer on Twitter, go to